Source:http://linkedlifedata.com/resource/pubmed/id/18348302
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
2008-5-5
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0008-543X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
112
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2324-5; author reply 2325
|
pubmed:meshHeading |
pubmed-meshheading:18348302-Adult,
pubmed-meshheading:18348302-Anticonvulsants,
pubmed-meshheading:18348302-Female,
pubmed-meshheading:18348302-Humans,
pubmed-meshheading:18348302-Myelodysplastic Syndromes,
pubmed-meshheading:18348302-Pilot Projects,
pubmed-meshheading:18348302-Remission Induction,
pubmed-meshheading:18348302-Valproic Acid
|
pubmed:year |
2008
|
pubmed:articleTitle |
Valproic acid for the treatment of myeloid malignancies.
|
pubmed:publicationType |
Letter,
Comment,
Case Reports
|